@ImmunoBiochem is pleased to announce a multi-target license and option agreement with @ImmunoGenInc to develop next-generation ADCs. https://t.co/nUxV0t3Ghe
💫 ImmunoBiochem (@ImmunoBiochem) is improving patient outcomes through innovations in biological therapeutics.
Visit their website at https://t.co/hH4pbDt0Nx. 9/11
💫 We're welcoming our first group of startups working in the health, chemical & life sciences — diverse companies founded by #UofT students, alumni, faculty or founders from an external partner program.
Meet the teams below and at https://t.co/xnWK9fxitg. #UofTStartup 1/11
DYK: #JLABSToronto has supported 88 startup companies over the past 5 years!
Learn more about how our Canadian Johnson & Johnson Innovation - JLABS site has empowered innovators + created an impact on the Toronto healthcare ecosystem: https://t.co/au7lHWr3hl
Canadian healthcare companies are headed to NYC, Nov 5-6 for @OBIO’s Health Investment Showcase. Don’t miss a chance to “give your portfolio a shot in the arm” @globeandmail@theGHIF@GVteam@domainvc
ImmunoBiochem is at #BIO2018 this week, June 4-7, participating in the Ontario/Canada Pavilion, Coast-to-Coast Competition on the Canadian Stage, and BIO One-on-One Partnering in the BIO Business Forum! https://t.co/xnK44fgz5F
Today we celebrate #JLABSToronto#TwoYearAnniversary with a Super Spotlight ft over 30+ resident companies sharing more about their technology https://t.co/08L1yXgtQr
I had the great honour of introducing @ImmunoBiochem to Their Majesties Queen Mathilde & King Philippe of Belgium on their state visit to Canada #BELCAN2018
ImmunoBiochem wins in the Innovation Challenge at RESI in San Francisco during the #JPM Healthcare Conference Week
https://t.co/8Gqw1EScZL https://t.co/lwmeXIoGLx
@ImmunoBiochem is an Innovation Challenge Finalist @ RESI #JPM18 in San Francisco - Tuesday, Jan 9, 2018
https://t.co/syVgEJCaNd
https://t.co/GgRZoVcc1m